Acta Medica Scandinavica

Cover image for Acta Medica Scandinavica

January/December 1975

Volume 197, Issue S576

Pages 7–146

Currently known as: Journal of Internal Medicine

  1. Speech of Welcome

    1. Top of page
    2. Speech of Welcome
    3. Opening Address
    4. Introduction
    5. Vaccination
    6. Panel Discussion
    7. Lifelong Drug Therapy
    8. Panel Discussion
    9. Preventive Medicine-Cost/Benefit Aspects
    10. General Panel Discussion
    11. Acknowledgements
    1. Speech of welcome (page 7)

      LENNART WESTMAN

      Article first published online: 24 APR 2009 | DOI: 10.1111/j.0954-6820.1975.tb14800.x

  2. Opening Address

    1. Top of page
    2. Speech of Welcome
    3. Opening Address
    4. Introduction
    5. Vaccination
    6. Panel Discussion
    7. Lifelong Drug Therapy
    8. Panel Discussion
    9. Preventive Medicine-Cost/Benefit Aspects
    10. General Panel Discussion
    11. Acknowledgements
    1. Opening address (pages 9–10)

      BROR REXED

      Article first published online: 24 APR 2009 | DOI: 10.1111/j.0954-6820.1975.tb14801.x

  3. Introduction

    1. Top of page
    2. Speech of Welcome
    3. Opening Address
    4. Introduction
    5. Vaccination
    6. Panel Discussion
    7. Lifelong Drug Therapy
    8. Panel Discussion
    9. Preventive Medicine-Cost/Benefit Aspects
    10. General Panel Discussion
    11. Acknowledgements
    1. You have free access to this content
      Towards Prevention and Health (pages 13–17)

      J. N. MORRIS

      Article first published online: 24 APR 2009 | DOI: 10.1111/j.0954-6820.1975.tb14802.x

    2. You have free access to this content
      Prevention by Vaccination (pages 19–24)

      W. CHAS COCKBURN

      Article first published online: 24 APR 2009 | DOI: 10.1111/j.0954-6820.1975.tb14803.x

  4. Vaccination

    1. Top of page
    2. Speech of Welcome
    3. Opening Address
    4. Introduction
    5. Vaccination
    6. Panel Discussion
    7. Lifelong Drug Therapy
    8. Panel Discussion
    9. Preventive Medicine-Cost/Benefit Aspects
    10. General Panel Discussion
    11. Acknowledgements
    1. Introduction (pages 27–28)

      ERLING NORRBY

      Article first published online: 24 APR 2009 | DOI: 10.1111/j.0954-6820.1975.tb14804.x

    2. Smallpox Vaccination: The End of an Era (pages 29–38)

      DAVID T. KARZON

      Article first published online: 24 APR 2009 | DOI: 10.1111/j.0954-6820.1975.tb14805.x

    3. Measles and Rubella Vaccination (pages 39–44)

      A. JOHN BEALE

      Article first published online: 24 APR 2009 | DOI: 10.1111/j.0954-6820.1975.tb14806.x

    4. New Approaches to the Prevention of Influenza (pages 45–48)

      EDWIN D. KILBOURNE

      Article first published online: 24 APR 2009 | DOI: 10.1111/j.0954-6820.1975.tb14807.x

    5. Interferon Therapy: Obvious and not so Obvious Applications (pages 49–53)

      ION GRESSER

      Article first published online: 24 APR 2009 | DOI: 10.1111/j.0954-6820.1975.tb14808.x

    6. The Newer Live Virus Vaccines (pages 55–63)

      MAURICE R. HILLEMAN

      Article first published online: 24 APR 2009 | DOI: 10.1111/j.0954-6820.1975.tb14809.x

    7. Killed Vaccines—Principal Aspects (pages 65–69)

      SVEN GARD

      Article first published online: 24 APR 2009 | DOI: 10.1111/j.0954-6820.1975.tb14810.x

  5. Panel Discussion

    1. Top of page
    2. Speech of Welcome
    3. Opening Address
    4. Introduction
    5. Vaccination
    6. Panel Discussion
    7. Lifelong Drug Therapy
    8. Panel Discussion
    9. Preventive Medicine-Cost/Benefit Aspects
    10. General Panel Discussion
    11. Acknowledgements
    1. Panel discussion (pages 71–78)

      Article first published online: 24 APR 2009 | DOI: 10.1111/j.0954-6820.1975.tb14811.x

  6. Lifelong Drug Therapy

    1. Top of page
    2. Speech of Welcome
    3. Opening Address
    4. Introduction
    5. Vaccination
    6. Panel Discussion
    7. Lifelong Drug Therapy
    8. Panel Discussion
    9. Preventive Medicine-Cost/Benefit Aspects
    10. General Panel Discussion
    11. Acknowledgements
    1. Introduction (pages 81–82)

      LARS WERKÖ

      Article first published online: 24 APR 2009 | DOI: 10.1111/j.0954-6820.1975.tb14812.x

    2. Hypertension and the Coummunity (pages 83–91)

      RALPH READER

      Article first published online: 24 APR 2009 | DOI: 10.1111/j.0954-6820.1975.tb14813.x

    3. Prevention of Commplications in Hypertension (pages 93–97)

      EDWARD D. FREIS

      Article first published online: 24 APR 2009 | DOI: 10.1111/j.0954-6820.1975.tb14814.x

    4. Treatment of Hypertension in a Swedish Community—the Problem of Borderline Hypertension (pages 99–108)

      LARS WILHELMSEN

      Article first published online: 24 APR 2009 | DOI: 10.1111/j.0954-6820.1975.tb14815.x

  7. Panel Discussion

    1. Top of page
    2. Speech of Welcome
    3. Opening Address
    4. Introduction
    5. Vaccination
    6. Panel Discussion
    7. Lifelong Drug Therapy
    8. Panel Discussion
    9. Preventive Medicine-Cost/Benefit Aspects
    10. General Panel Discussion
    11. Acknowledgements
    1. Panel discussion (pages 109–119)

      Article first published online: 24 APR 2009 | DOI: 10.1111/j.0954-6820.1975.tb14816.x

  8. Preventive Medicine-Cost/Benefit Aspects

    1. Top of page
    2. Speech of Welcome
    3. Opening Address
    4. Introduction
    5. Vaccination
    6. Panel Discussion
    7. Lifelong Drug Therapy
    8. Panel Discussion
    9. Preventive Medicine-Cost/Benefit Aspects
    10. General Panel Discussion
    11. Acknowledgements
    1. Utilization of Cost/Benefit Analysis in Planning Prevention Programs (pages 123–128)

      DAVID J. SENCER and NORMAN W. AXNICK

      Article first published online: 24 APR 2009 | DOI: 10.1111/j.0954-6820.1975.tb14817.x

    2. Present State of Cost/Benefit Analysis in Medical Evaluation (pages 129–134)

      INGEMAR STÅHL

      Article first published online: 24 APR 2009 | DOI: 10.1111/j.0954-6820.1975.tb14818.x

    3. Consequences of maternal rebella in adults (pages 135–136)

      ROLF LUNDSTRÖM

      Article first published online: 24 APR 2009 | DOI: 10.1111/j.0954-6820.1975.tb14819.x

  9. General Panel Discussion

    1. Top of page
    2. Speech of Welcome
    3. Opening Address
    4. Introduction
    5. Vaccination
    6. Panel Discussion
    7. Lifelong Drug Therapy
    8. Panel Discussion
    9. Preventive Medicine-Cost/Benefit Aspects
    10. General Panel Discussion
    11. Acknowledgements
    1. General panel discussion (pages 139–145)

      Article first published online: 24 APR 2009 | DOI: 10.1111/j.0954-6820.1975.tb14820.x

  10. Acknowledgements

    1. Top of page
    2. Speech of Welcome
    3. Opening Address
    4. Introduction
    5. Vaccination
    6. Panel Discussion
    7. Lifelong Drug Therapy
    8. Panel Discussion
    9. Preventive Medicine-Cost/Benefit Aspects
    10. General Panel Discussion
    11. Acknowledgements
    1. Acknowledgements (page 146)

      Article first published online: 24 APR 2009 | DOI: 10.1111/j.0954-6820.1975.tb14821.x

SEARCH

SEARCH BY CITATION